Expertise in Biological and Medical Data Analysis
AltraBio is a research company specializing in the analysis of biological and medical data using advanced statistical methods and artificial intelligence. We extract relevant information and provide valuable insights from complex datasets.
Global Recognition
With over 15 years of experience, AltraBio is globally recognized by pharmaceutical companies, medical device manufacturers, dermo-cosmetic firms, and academic research institutions across various life science sectors.
A Multidisciplinary Team
Our team comprises professionals with diverse expertise in medicine, biology, data science, and computer science. This multidisciplinary skill set enables us to offer more than just statistical analysis. We understand your specific challenges, contribute to study design, and provide biological and medical interpretations of your results.
A message from our CEO
“Over the past few decades, research in medicine and biology has seen remarkable technological advancements. These innovations enable the characterization of living organisms at the molecular level. Progress includes increased measured parameters, access to new information, improved precision, reduced costs, automation of measurement processes, and the ability to work with samples as small as single cells.
This has led to an explosion in the volume and complexity of molecular data generated, both in basic research and during clinical development. Concurrently, biological knowledge for interpreting this data is expanding, and algorithms are becoming more sophisticated.
AltraBio stands at the crossroads of these paths: Data, Knowledge, and Methods.
With our multidisciplinary expertise and over 15 years of experience, we analyze molecular and clinical data from R&D projects. We extract relevant information for academic and private researchers.
Moreover, through proprietary and unique artificial intelligence methods, we replicate human expertise for the analysis of cytometry data. This enables pharmaceutical companies to automatically and quickly analyze this type of data during their clinical trials.
These diverse capabilities are reflected in numerous scientific articles.”
Meet the Team
